OBJECTIVES: Earlier studies have demonstrated the use of inactivated recombinant E. coli (bacterins), to protect against Clostridium spp. in vaccinated animals. These bacterins have a simpler, safer, and faster production process. However, these bacterins carry expression plasmids, containing antibiotic resistance gene, which could be assimilate accidentally by environmental microorganisms. Considering this, we aimed to impair this plasmids using formaldehyde at different concentrations. RESULTS: This compound inactivated the highest density of cells in 24 h. KanR cassette amplification was found to be impaired with 0.8% for 24 h or 0.4% for 72 h. Upon electroporation, E. coli DH5α ultracompetent cells were unable to acquire the plasmids extracted from the bacterins after inactivation procedure. Formaldehyde-treated bacterins were incubated with other viable strains of E. coli, leading to no detectable gene transfer. CONCLUSIONS: We found that this compound is effective as an inactivation agent. Here we demonstrate the biosafety involving antibiotic resistance gene of recombinant E. coli vaccines allowing to industrial production and animal application.
OBJECTIVES: Earlier studies have demonstrated the use of inactivated recombinant E. coli (bacterins), to protect against Clostridium spp. in vaccinated animals. These bacterins have a simpler, safer, and faster production process. However, these bacterins carry expression plasmids, containing antibiotic resistance gene, which could be assimilate accidentally by environmental microorganisms. Considering this, we aimed to impair this plasmids using formaldehyde at different concentrations. RESULTS: This compound inactivated the highest density of cells in 24 h. KanR cassette amplification was found to be impaired with 0.8% for 24 h or 0.4% for 72 h. Upon electroporation, E. coli DH5α ultracompetent cells were unable to acquire the plasmids extracted from the bacterins after inactivation procedure. Formaldehyde-treated bacterins were incubated with other viable strains of E. coli, leading to no detectable gene transfer. CONCLUSIONS: We found that this compound is effective as an inactivation agent. Here we demonstrate the biosafety involving antibiotic resistance gene of recombinant E. coli vaccines allowing to industrial production and animal application.
Entities:
Keywords:
Antibiotic resistance gene; Chemical inactivation; Recombinant vaccines; Selection marker
Authors: Marcos Roberto A Ferreira; Francisco D Dos Santos; Carlos Eduardo P da Cunha; Clóvis Moreira; Rafael A Donassolo; Carolina G Magalhães; Alessandra S Belo Reis; Carlos Magno C Oliveira; José D Barbosa; Fábio P L Leite; Felipe M Salvarani; Fabricio R Conceição Journal: Vaccine Date: 2018-10-30 Impact factor: 3.641
Authors: Marcos Roberto A Ferreira; Jaqueline F Motta; Morgana L Azevedo; Lucas M Dos Santos; Clóvis Moreira Júnior; Rafael R Rodrigues; Rafael A Donassolo; Alessandra Dos S Belo Reis; José D Barbosa; Felipe M Salvarani; Ângela N Moreira; Fabricio R Conceição Journal: Anaerobe Date: 2019-07-09 Impact factor: 3.331
Authors: G M S G Moreira; C E P Cunha; F M Salvarani; L A Gonçalves; P S Pires; F R Conceição; F C F Lobato Journal: Anaerobe Date: 2014-06-12 Impact factor: 3.331
Authors: Carlos E P Cunha; Gustavo M S G Moreira; Felipe M Salvarani; Monique S Neves; Francisco C F Lobato; Odir A Dellagostin; Fabricio R Conceição Journal: Vaccine Date: 2013-11-16 Impact factor: 3.641